PLAY PODCASTS
Barriers and Solutions to Expanding PrEP Uptake: Transgender Women
Episode 219

Barriers and Solutions to Expanding PrEP Uptake: Transgender Women

Listen to Timothy J. Wilkin, MD, MPH, discuss barriers to PrEP uptake for transgender women.

Decera Clinical Education Infectious Disease Podcast · Timothy Wilkin MD MPH

November 15, 20224m 52s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, focuses on transgender women. His discussion includes: 

  • Barriers to PrEP uptake in transgender women
  • High PrEP adherence among transgender women and transfeminine individuals in a real-world healthcare setting in New York City

Presenter: 

Timothy J. Wilkin, MD, MPH
Professor of Medicine
Division of Infectious Diseases
Weill Medical College of Cornell University
New York, New York

Link to full program:
http://bit.ly/3UFUl2b

Follow along with the slides at:
https://bit.ly/3EcaYg0


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

transgender womenprep uptaketransfeminine individualcabotegravirdaily adherencestifeminizing hormone therapysubstance useprep counselingdrug interactionspre-exposure prophylaxisprepprep monitoringprep adherenceftcprep adverse eventsprep discontinuationtransfemininetenofovir disoproxil fumarateemtricitabinegender-affirming hormone therapygahttdfbarriers to carehiv risk assessmentstigmaemtricitabine/tenofovirgender-affirmingftc/tdfftc/taftgwfhtadherencetfvsexually transmitted infectiontenofovirtfifphiv